Skip to main content
. 2019 Oct 29;7(10):e2484. doi: 10.1097/GOX.0000000000002484

Table 6.

Comparison of Variables between Cases Developing Postoperative Functional Weakness and Those Not

Variables Postop Functional Weakness P
Absence (n = 63, 82.9%) Presence (n = 13, 17.1%)
Patient demographics
 Age, y 47.7 (±6.7) 51.1 (±8.2) 0.176
 BMI, kg/m2 23.5 (±2.4) 24.9 (±1.9) 0.023
  Overweight/obesity 15 (23.8%) 7 (53.8%) 0.030
 Diabetes 1 (1.3%) 0 0.647
 Active smoking 1 (1.3%) 0 0.647
 Hypertension 6 (9.5%) 3 (23.1%) 0.169
 Previous abdominal operation history 7 (11.1%) 3 (23.1%) 0.245
 Midline vertical scar 1 (1.6%) 1 (7.7%) 0.211
 Pfannenstiel incision scar 6 (9.5%) 2 (15.4%) 0.531
 Abdominal circumference 86.2 (±7.2) 87.2 (±7.7) 0.817
Operation related
 Timing 0.119
 Immediate 39 (88.6%) 5 (11.4%)
 Delayed 24 (75.0%) 8 (25.0%)
 Harvested flap size
 Width 28.7 (±4.7) 32.5 (±5.2) 0.025
 Height 12.7 (±1.1) 13.0 (±0.9) 0.715
 Harvested flap weight 674.3 (±247.4) 816.7 (±314.7) 0.166
 Rows of harvested perforators 0.651
 Unilateral 29 (87.9%) 4 (12.1%) 0.600
 Single row based 22 (88.0%) 3 (12.0%)
 Both rows based (medial and lateral) 7 (87.5%) 1 (12.5%)
 Bilateral 34 (79.1%) 9 (20.9%)
 No. harvested perforators 4.2 (±1.8) 4.6 (±1.1) 0.310
 1–3 (n, %) 24 (85.7%) 4 (14.3%) 0.618
 4 or more (n, %) 39 (81.3%) 9 (18.7%)
 Width of transected muscle, cm 2.0 (±0.9) 2.8 (±1.4) 0.051
 Partial thickness 1.7 (±1.1) 2.3 (±0.8) 0.019
 Full thickness 0.3 (±0.7) 0.4 (±1.1) 0.546
 Width ratio of transected muscle to entire muscle 0.17 (±0.08) 0.22 (±0.10) 0.087
 Partial thickness 0.14 (±0.09) 0.19 (±0.06) 0.046
 Full thickness 0.03 (±0.06) 0.03 (±0.08) 0.558
 Receiving chemotherapy after reconstruction 14 (22.2%) 2 (15.4%) 0.582

Postop, postoperative.